Astrazzinica stopped the influenza vaccine launch in Switzerland amid pricing dispute

Astrazzinica stopped the influenza vaccine launch in Switzerland amid pricing dispute

Astrazinica has suspended the distribution of influenza vaccine, which is used in the spray of the nose in Switzerland, due to a price dispute with health officials, according to the Zone Taj Tsaitung newspaper.
The Swiss authorities called the company in 2020 regarding plans to provide the vaccine for all children between the ages of two and 11 years, according to Bloomberg News Agency on Sunday.

The Federal Health Department is now plans to vaccinate patients and children at a great risk, who fear injection, at a maximum price of 16. 90 Frank (17. 95 dollars) per dose, according to the newspaper.
Officials informed the company this in early October, a short period of delivery of the first batch of doses.
The authorities did not find a “solution for payment” with the manufacturer, according to the Federal Health Department.
Astrazinica negotiated to hand over 50 thousand doses at 22.

20 Frank each, said Catherine de Vos, head of the Swiss company unit, told the newspaper.
She added that with small quantities, the launch of the vaccine is not financially feasible. The newspaper said that the company wants to donate the 10,000 doses that were already delivered to children’s hospitals and clinics, instead of leaving them until its validity ends..

About Author

World